Keyword: Kymab

Troy A. Pentecost has been appointed to the additional positions of president and interim senior executive officer, effective immediately.

Kymab raises $100M to take antibodies into the clinic

Kymab has raised $100 million (€94 million) to fund the advance of its lead candidates into the clinic. The Series C round, which attracted new Chinese investors, brings the total raised by the early-stage British antibody specialist up to $220 million.